How to Buy Pelthos Therapeutics Stock

Pelthos Therapeutics Inc

Pelthos Therapeutics is a biotech company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker PTHS on the NYSEMKT exchange.

Pelthos Therapeutics stock last closed at $32.69, up 2.09% from the previous day, and has increased 259.23% in one year. It has overperformed other stocks in the Biotechnology industry by 3.08 percentage points. Pelthos Therapeutics stock is currently +626.44% from its 52-week low of $4.50, and -39.79% from its 52-week high of $54.29.

There are currently 3.04M PTHS shares outstanding. The market capitalization of PTHS is $99.45M. In the last 24 hours, 18,300 PTHS shares were traded.

How to Buy Pelthos Therapeutics Stock

Not sure how to invest in Pelthos Therapeutics stock? Here's how.

  1. Figure out where to buy Pelthos Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Pelthos Therapeutics stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Put funds into your investment account: Choose your payment method and add your details.
  4. Analyze Pelthos Therapeutics stock: The Pelthos Therapeutics ticker symbol is PTHS. Is Pelthos Therapeutics stock a good investment? Should you buy shares of PTHS? How do PTHS's underlying business fundamentals look? Do top analysts think Pelthos Therapeutics is a good buy? Why has PTHS's stock price moved recently? (Hint: Our stock research website can help you understand if PTHS is a good stock to buy).
  5. Execute your PTHS buy order: Decide if you will purchase PTHS shares at the current market price or use a limit order to purchase PTHS shares at a particular price.
  6. Get the latest scoop on your PTHS position: Create a watchlist to key updates about your investment in Pelthos Therapeutics shares.

Step 1: Figure out where to buy Pelthos Therapeutics stock

You will need an online brokerage account to access the NYSEMKT market and buy PTHS stock.

A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best place to buy stocks. eToro gives you:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen the best brokerage, you'll need to fill out some personal information so you can buy PTHS today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open your new trading account.
  1. Send your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've finished signing up on the highest rated stock app, you need to deposit funds:

Watch the tutorial below for more details depositing funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Pelthos Therapeutics stock

Once you have figured out the best place to buy Pelthos Therapeutics stock, it's very important to evaluate their stock before you invest, so you actually comprehend the risk as well as the upside.

Pelthos Therapeutics stock at a glance

PTHS Price
$32.69
1w %
5.45%
1y %
259.23%
5y %
N/A
P/E
-2.23x
P/B
-15.31x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$9.04M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$99.45M
Next Earnings
N/A
Next Dividend
N/A

Pelthos Therapeutics Overview

WallStreetZen was built to help everyday investors do more accurate fundamental analysis.

You can see all of the due diligence checks on PTHS's stock page.

Is PTHS stock overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PTHS's fair value.

You can access more valuation analysis on PTHS's stock here.

PTHS Financial Health

Pros:

  • There are more short-term assets than long-term liabilities on the PTHS balance sheet.

Cons:

  • PTHS debt to equity ratio of -1.13 is negative.
  • Total PTHS debt is still negative.
  • PTHS has cash burn of 1927446. It does not have sufficient cash and short-term investments to cover this.
  • There are more short-term liabilities than short-term assets on the PTHS balance sheet.
  • PTHS has $59.17k in cash and short term investments. This is not sufficient to cover its annual cash burn of $1.93M.

Do Wall Street analysts think it's a good time to buy PTHS stock

Out of 1 Equities analysts who give forecasts on PTHS, the consensus analyst rating on PTHS is a Buy

Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are forecasting on the Pelthos Therapeutics stock forecast page.

PTHS Technical Indicators

SMA10
31.76
SMA20
27.45
SMA50
23.37
SMA100
17.72
SMA200
15.92
MACD
3.18
MACD Signal
2.81
MACD Histogram
0.37
RSI
66.5
Stochastic %K
93.93
Stochastic %D
93.9
StochRSI %K
48.46
StochRSI %D
50.85

Are PTHS executives and large shareholders buying or selling the stock?

In the past 12 months, executives and large shareholders at PTHS have bought more shares than they have sold.

Todd C. Davis, Director of PTHS, was the latest PTHS insider to buy. They bought $15,000,000.00 worth of PTHS stock on Jul 1, 2025.

Dig into more about who owns PTHS stock here.

Does PTHS provide a stable income stream?

No, Pelthos Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about PTHS

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Execute your PTHS buy order

You have two main order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a given price, use a limit order.

Hit the Open Trade button and your broker will place your order.

If you want more assistance investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest scoop on your PTHS position

Now that you own some shares in PTHS, you'll want to stay up-to-date on your investment.

Put PTHS on a watchlist to track your PTHS stock.

PTHS Feed

How to Buy Stock in Pelthos Therapeutics

To summarize, here are the 6 steps for buying Pelthos Therapeutics stock:

  1. Figure out where to buy Pelthos Therapeutics stock
  2. Sign up for a brokerage account
  3. Put funds into your investment account
  4. Analyze Pelthos Therapeutics stock
  5. Execute your PTHS buy order
  6. Get the latest scoop on your PTHS position

If you are looking for a online brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to watch your new investment in Pelthos Therapeutics, add PTHS to your watchlist below.

NYSEMKT: PTHS
$32.69+0.67 (+2.09%)
Updated Sep 17, 2025
Open eToro Account
Your capital is at risk.
NYSEMKT: PTHS
$32.69+0.67 (+2.09%)
Updated Sep 17, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Pelthos Therapeutics share?

As of Sep 17, 2025, it costs $32.69 to buy one share of Pelthos Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.306 shares of PTHS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Pelthos Therapeutics stock?

According to 1 Wall Street analysts who monitor Pelthos Therapeutics, their consensus recommendation is to buy Pelthos Therapeutics stock.

What is the best way to buy Pelthos Therapeutics stock?

One way to place an order for Pelthos Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.